MSCV-Myc-IRES-RFP Citations (7)

Originally described in: A mouse model of the most aggressive subgroup of human medulloblastoma.
Kawauchi D, Robinson G, Uziel T, Gibson P, Rehg J, Gao C, Finkelstein D, Qu C, Pounds S, Ellison DW, Gilbertson RJ, Roussel MF Cancer Cell. 2012 Feb 14;21(2):168-80. PubMed Journal

---

Articles Citing MSCV-Myc-IRES-RFP

Articles
MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib. Wirth M, Stojanovic N, Christian J, Paul MC, Stauber RH, Schmid RM, Hacker G, Kramer OH, Saur D, Schneider G. Nucleic Acids Res. 2014;42(16):10433-47. doi: 10.1093/nar/gku763. Epub 2014 Aug 21. PubMed
PAF-Myc-Controlled Cell Stemness Is Required for Intestinal Regeneration and Tumorigenesis. Kim MJ, Xia B, Suh HN, Lee SH, Jun S, Lien EM, Zhang J, Chen K, Park JI. Dev Cell. 2018 Mar 12;44(5):582-596.e4. doi: 10.1016/j.devcel.2018.02.010. PubMed
gamma-Catenin-Dependent Signals Maintain BCR-ABL1(+) B Cell Acute Lymphoblastic Leukemia. Luong-Gardiol N, Siddiqui I, Pizzitola I, Jeevan-Raj B, Charmoy M, Huang Y, Irmisch A, Curtet S, Angelov GS, Danilo M, Juilland M, Bornhauser B, Thome M, Hantschel O, Chalandon Y, Cazzaniga G, Bourquin JP, Huelsken J, Held W. Cancer Cell. 2019 Apr 15;35(4):649-663.e10. doi: 10.1016/j.ccell.2019.03.005. PubMed
A combination strategy targeting enhancer plasticity exerts synergistic lethality against BETi-resistant leukemia cells. Guo L, Li J, Zeng H, Guzman AG, Li T, Lee M, Zhou Y, Goodell MA, Stephan C, Davies PJA, Dawson MA, Sun D, Huang Y. Nat Commun. 2020 Feb 6;11(1):740. doi: 10.1038/s41467-020-14604-6. PubMed
Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling. Lopusna K, Nowialis P, Opavska J, Abraham A, Riva A, Opavsky R. EBioMedicine. 2021 Jan;63:103191. doi: 10.1016/j.ebiom.2020.103191. Epub 2021 Jan 6. PubMed
Identification of Autophagy-Related Genes as Targets for Senescence Induction Using a Customizable CRISPR-Based Suicide Switch Screen. Schepers A, Jochems F, Lieftink C, Wang L, Pogacar Z, Leite de Oliveira R, De Conti G, Beijersbergen RL, Bernards R. Mol Cancer Res. 2021 Jun 22. pii: 1541-7786.MCR-21-0146. doi: 10.1158/1541-7786.MCR-21-0146. PubMed
An IRF4-MYC-mTORC1 Integrated Pathway Controls Cell Growth and the Proliferative Capacity of Activated B Cells during B Cell Differentiation In Vivo. Patterson DG, Kania AK, Price MJ, Rose JR, Scharer CD, Boss JM. J Immunol. 2021 Oct 1;207(7):1798-1811. doi: 10.4049/jimmunol.2100440. Epub 2021 Sep 1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.